等待開盤 06-26 09:30:00 美东时间
+0.070
+1.61%
Orasure Technologies ( ($OSUR) ) just unveiled an update. On June 11, 2026, Ora...
06-11 21:27
OraSure Technologies announced FDA clearance for its Colli-Pee™•Dx Urine Collection Kit, designed for at-home urine sample collection to detect STIs like Chlamydia, gonorrhea, trichomoniasis, and mycoplasma. The kit, developed with Roche’s cobas® molecular testing systems, enables private, convenient sample collection in any setting, improving accessibility for underserved populations and supporting large-scale STI screening programs.
06-11 12:00
经济观察网 奥瑞许科技于美东时间2026年5月6日盘后发布2026年第一季度财报。 业绩经营情况: 关键财务表现如下: 以上内容基于公开资料整理,不构成投资建议...
05-26 02:46
OraSure director Steven Kyle Boyd buys 75,000 shares for $224,750 OraSure Technologies: Director Steven Kyle Boyd bought 75,000 shares of common stock in open-market purchases priced between USD 2.98 and USD 3.02. Directly held stake rose to 113,462 shares following the transactions. Disclaimer: Thi
05-15 08:56
OraSure files Form 3 for new director John D. Bertrand, no securities owned OraSure Technologies filed an initial Form 3 naming John D. Bertrand as a director, with the report triggered by an April 16, 2026 event. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative
05-15 08:54
Orasure (($OSUR)) has held its Q1 earnings call. Read on for the main highlight...
05-08 10:19
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
An announcement from Orasure Technologies ( ($OSUR) ) is now available. On Apri...
04-17 20:18
OraSure appoints Digital Diagnostics co-founder John Bertrand to board OraSure appointed John D. Bertrand to board of directors as independent director, effective immediately. Bertrand co-founded Digital Diagnostics Inc., most recently serving as CEO and scaling it from research-stage to global comm
04-17 08:13
OraSure Technologies appoints John D. Bertrand to its Board of Directors, leveraging his extensive experience in AI-enabled diagnostics. The company also enters a Cooperation Agreement with Altai Capital, under which Altai withdraws its director nominations and commits to regular strategic discussions. Additionally, OraSure plans to seek shareholder approval at its 2026 Annual Meeting to declassify the Board, aiming to enhance governance and shar...
04-17 00:10